Mark Andrew Sherman Sells 9,109 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) EVP Mark Andrew Sherman sold 9,109 shares of the business’s stock in a transaction that occurred on Tuesday, December 16th. The stock was sold at an average price of $66.73, for a total transaction of $607,843.57. Following the completion of the transaction, the executive vice president directly owned 73,054 shares of the company’s stock, valued at approximately $4,874,893.42. This represents a 11.09% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Mark Andrew Sherman also recently made the following trade(s):

• On Wednesday, December 17th, Mark Andrew Sherman sold 2,491 shares of Dolby Laboratories stock. The shares were sold at an average price of $67.26, for a total transaction of $167,544.66.
• On Monday, December 1st, Mark Andrew Sherman sold 4,500 shares of Dolby Laboratories stock. The stock was sold at an average price of $67.56, for a total transaction of $304,020.00.

Dolby Laboratories Stock Performance

DLB traded up $0.29 during trading on Wednesday, reaching $67.09. The stock had a trading volume of 575,384 shares, compared to its average volume of 610,696. The business has a 50-day moving average of $66.88 and a 200-day moving average of $71.25. Dolby Laboratories has a one year low of $64.02 and a one year high of $89.66. The stock has a market cap of $6.41 billion, a PE ratio of 25.51 and a beta of 0.89.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. The firm had revenue of $307.02 million during the quarter, compared to analysts’ expectations of $305.76 million. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The company’s revenue for the quarter was up .7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. Equities research analysts forecast that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd were given a dividend of $0.36 per share. The ex-dividend date was Tuesday, December 2nd. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a yield of 2.1%. Dolby Laboratories’s dividend payout ratio (DPR) is 54.75%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of DLB. Allworth Financial LP boosted its stake in shares of Dolby Laboratories by 99.6% during the 3rd quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock valued at $73,000 after purchasing an additional 502 shares in the last quarter. Swiss Life Asset Management Ltd purchased a new stake in Dolby Laboratories in the third quarter worth about $210,000. Advisory Services Network LLC purchased a new stake in Dolby Laboratories in the third quarter worth about $102,000. XTX Topco Ltd bought a new stake in Dolby Laboratories during the 3rd quarter valued at approximately $741,000. Finally, Verition Fund Management LLC grew its holdings in shares of Dolby Laboratories by 172.4% during the 3rd quarter. Verition Fund Management LLC now owns 35,409 shares of the electronics maker’s stock worth $2,563,000 after acquiring an additional 22,409 shares during the period. Institutional investors own 58.56% of the company’s stock.

Analysts Set New Price Targets

DLB has been the subject of a number of recent research reports. Barrington Research lowered their price objective on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a report on Wednesday, November 19th. Robert W. Baird initiated coverage on shares of Dolby Laboratories in a research note on Friday, September 5th. They issued a “neutral” rating and a $74.00 price target for the company. Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Monday. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $92.00.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.